Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 21;16:100156. doi: 10.1016/j.medntd.2022.100156

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Author(s)

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 4 — Effects of CEP treatment on GX_P2V-induced aberrant glycosylation of proteins in Vero E6 cells. A. Venn diagram shows the effect of CEP on the aberrant glycosylation of proteins induced by GX_P2V. The number in purple circle indicates the glycosylation sites those are differentially expressed (with Vero_P/Vero Fc ≥ 2) in response to GX_P2V treatment (GX_P2V). The number in light red circle shows the glycosylation sites are in normal state (with Vero_C_P/Vero, 0.667 ≥ Fc ≤ 1.5) in presence of CEP (CEP + GX_P2V). The number in the overlap of the two circle shows that there are 13 site (on 10 proteins) out of 81 sites (on 66 proteins) GX_P2V-induced aberrant glycosylation sites in normal state in presence of CEP. B. Reactome Pathway Analysis of glycosylation sites on 10 glycoproteins affected by CEP. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)